Trained immunity in newborn infants of HBV-infected mothers
about
Management of HBV and HBV/HDV-Associated Liver CirrhosisRecent advances in understanding and diagnosing hepatitis B virus infectionEstimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental modelInnate immune recognition of hepatitis B virus.Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent MechanismThe role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde.Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cureInnate detection of hepatitis B and C virus and viral inhibition of the response.Advances in therapeutics for chronic hepatitis B.Prospects and progress of DNA vaccines for treating hepatitis B.HBV DNA Integration: Molecular Mechanisms and Clinical ImplicationsImmune balance in Hepatitis B Infection: Present and Future Therapies.Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease.Innate immune memory: Implications for host responses to damage-associated molecular patterns.Trained immunity: A program of innate immune memory in health and disease.Broad-spectrum antiviral properties of andrographolide.Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics.In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes.New antivirals for the treatment of chronic hepatitis B.Tolerance and immunity to pathogens in early life: insights from HBV infection.Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses.Mechanisms of Hepatitis B Virus Persistence.New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection.Evaluation of trained immunity by β-1, 3 (d)-glucan on murine monocytes in vitro and duration of response in vivo.Hepatitis B cure: From discovery to regulatory approval.Transfer of maternal immunity and programming of the newborn immune system.Timing of the human prenatal antibody response to Plasmodium falciparum antigens.Infectious Agents as Stimuli of Trained Innate Immunity.Global strategies are required to cure and eliminate HBV infection.Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.A global perspective on hepatitis B-related single nucleotide polymorphisms and evolution during human migration.
P2860
Q26740323-DD2146CD-CF1C-4099-BB39-7F0345C7F36FQ28067419-DE904BCB-6F5A-4139-9E58-27A8568322ACQ33767254-974148B8-F3FC-4F36-A8A5-4E8263FC8E75Q36080441-3D6D8E7B-FB1B-4176-B209-FE81C4BBBFFCQ37073307-ADFECF20-78E5-4D68-B683-168895A62665Q37538505-CF7A3ECE-5F34-4F63-ACBF-41846DB9E461Q38553065-09859FC5-D2C4-490D-A4D7-E73F1284F44AQ38560972-BBA69D0F-4392-4EFA-890D-AF94430FDB64Q38585657-ACE20F69-67E7-40AA-91A2-CC104C557EBFQ38664504-0C24D54B-4933-41C2-A86F-5F69875D7506Q38732528-7C651901-9A63-4365-9181-4C8D0C5373D0Q38733622-9DEF4912-FA02-4807-BBAE-FD5631EB82CAQ38764042-69DAD915-A732-45B8-A5B5-6C3F8486D0D9Q38771560-47F91D9E-E32B-48F2-8E53-7138E0DB5E0AQ38814347-E92DDC7C-9B91-4EC0-AFF4-5BE04B5A2FABQ39023188-A5DA71EF-88DD-4C40-8C2D-3DC661D783ECQ39136809-15D27FB4-DC7B-44D1-A060-33C56C49312CQ39298239-1A1A45F1-0313-4050-B990-67F7D657F5E6Q39315990-9B1678DA-63B0-4356-8219-ABCDEABFBCC8Q39419957-F32EB67D-6CB7-427B-A5CD-39F819F795A8Q40059882-0C006593-9C30-4584-BE55-5AC95A3D6FD4Q40077350-DB3EA394-C6C5-427E-9E11-B5A60C52EB2EQ40130098-16DF9137-4DD1-4905-A984-A624025AF9A3Q40321470-30A1C791-AD88-4C09-8519-A73CD7F9E68CQ41952398-6D60FC87-EA02-40E2-9924-FB2BAF05F546Q41991852-E3419653-4EC0-497D-A324-C49965599B34Q42364305-75749839-2B8E-441B-9E0E-161E05E537D9Q48104891-66342DE4-0F1E-4AAD-9B40-4082CFC29BADQ48860247-6E67C4A5-7646-4E47-BE52-BDDF985960CBQ49997050-9A3A57C1-A556-464E-9F17-CFEC0B2381B2Q52699092-951434EC-E335-498E-8D88-4C918261769C
P2860
Trained immunity in newborn infants of HBV-infected mothers
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Trained immunity in newborn infants of HBV-infected mothers
@ast
Trained immunity in newborn infants of HBV-infected mothers
@en
type
label
Trained immunity in newborn infants of HBV-infected mothers
@ast
Trained immunity in newborn infants of HBV-infected mothers
@en
prefLabel
Trained immunity in newborn infants of HBV-infected mothers
@ast
Trained immunity in newborn infants of HBV-infected mothers
@en
P2093
P2860
P50
P356
P1476
Trained immunity in newborn infants of HBV-infected mothers
@en
P2093
Adam J Gehring
Barbara Amadei
Elena Sandalova
Ernesto Guccione
Simonetta Urbani
Stefania Fieni
P2860
P2888
P356
10.1038/NCOMMS7588
P407
P577
2015-03-25T00:00:00Z